Nyxoah SA (NYXH) vs SkinHealth Systems (SKIN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
SkinHealth Systems (SKIN) has outperformed Nyxoah SA (NYXH) over the past year, gaining 791.7% versus a loss of 82.6%. Over five years, SKIN leads with a -57.1% price change compared with -96.0% for NYXH. Nyxoah SA is the larger company by market cap ($82.0 million vs $76.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NYXH | SKIN |
|---|---|---|
| Share price | $0.805 | $11.77 |
| Market cap | $81.98M | $76.68M |
| 1-day change | -7.01% | -3.13% |
| YTD return | -82.50% | +746.76% |
| 1-year return | -82.58% | +791.67% |
| 5-year return | -96.02% | -57.11% |
| Forward P/E | — | 2.63 |
| EPS (TTM) | $-1.83 | $-2.98 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $300.79M |
| Revenue growth (YoY) | — | -10.02% |
| Net income (latest FY) | — | $-9.52M |
| Gross margin | — | 65.28% |
| Operating margin | — | -6.92% |
| Net margin | — | -3.16% |
| 52-week high | $5.39 | $33.00 |
| 52-week low | $0.80 | $9.68 |
| Distance from 52-week high | -85.06% | -64.33% |
| Analyst consensus | none | hold |
| Avg. price target upside | +422.98% | +24.64% |
| Average volume | 318.65K | 43.46K |
| Shares outstanding | 101.84M | 6.51M |
| Employees | 153 | 613 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SKIN has outperformed NYXH by 874.2 percentage points over the past year.
About Nyxoah SA
NYXH stock →Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea.
Health Care · Medical/Dental Instruments · 153 employees
About SkinHealth Systems
SKIN stock →SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums.
Health Care · Medical/Dental Instruments · 613 employees
NYXH vs SKIN FAQ
Which is bigger, Nyxoah SA or SkinHealth Systems?
Nyxoah SA (NYXH) is larger, with a market capitalization of $81.98M compared with $76.68M for SkinHealth Systems (SKIN).
Which stock has performed better over the past year, NYXH or SKIN?
SKIN returned +791.67% over the past 12 months, compared with -82.58% for NYXH (price return, excluding dividends). Past performance does not predict future results.
Are Nyxoah SA and SkinHealth Systems in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.